This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Cell & Gene Therapy Manufacturing & Commercialization Europe

Speaking Proposals Due 17th May

  • 00
    Days
  • 00
    Hrs
  • 00
    Mins
  • 00
    Secs
Save the Date: 2-4 December 2024
Convention Centre DublinDublin, Ireland

Pierre Heimendinger
Chief Technical Officer at Smart Immune
Speaker

Profile

Pierre Heimendinger has a 30-year track record of expertise in process automation of allogeneic and autologous CAR-Treg, Treg, viral vectors, and vaccines. Prior to joining Smart Immune as Chief Technical Officer, he held key managerial roles overseeing production, pharmaceutical development, and quality control departments at multiple pharma and biotech companies such as Aventis-Pasteur (Sanofi), Octapharma, Transgene, TxCell, and most recently, Sangamo Therapeutics. Pierre holds a PharmD from the Mérieux Institute in France.

Agenda Sessions

  • ProTcell: Manufacturing Challenges of T Cell Progenitor Based Therapy, A Phase III Strategy

    14:15